1 Qazi SA, Stoll BJ. Neonatal sepsis: a major global public health challenge. Pediatr Infect Dis J 2009; 28:S1–2.
2 Boghossian NS, Page GP, Bell EF, et al. Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J Pediatr 2013; 162: 1120–4.
3 Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011; 96: F9–14.
4 Tsai MH, Hsu JF, Chu SM, et al. Incidence, clinical characteristics, and risk factors for adverse outcome in neonates with late onset sepsis. Pediatr Infect Dis J 2014; 33: e7–13.
5 Hammoud MS, Al-Taiar A, Thalib L, et al. Incidence, aetiology and resistance of late-onset neonatal sepsis: a five-year prospective study. J Paediatr Child Health 2012; 48: 604–9.
6 Bizzarro MJ, Raskind C, Baltimore RS, et al. Seventy-five years of neonatal sepsis at Yale: 1928–2003. Pediatrics 2005; 116: 595–602.
7 Shim GH, Kim SD, Kim HS, et al. Trends in epidemiology of neonatal sepsis in a tertiary center in Korea: a 26-year longitudinal analysis, 1980–2005. J Korean Med Sci 2011; 26: 284–9
8 van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, et al. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 2010; 97: 22–8.
9 Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 2009; 123: 1314–19.
10 Al-Taiar A, Hammoud MS, Cuiqing L, et al. Neonatal infections in China, Malaysia, Hong Kong and Thailand. Arch Dis Child Fetal Neonatal Ed 2013; 98: F249–55.
11 Tröger B, Göpel W, Faust K, et al. Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network. Pediatr Infect Dis J 2014; 33: 238–43.
12 Morioka I, Morikawa S, Miwa A, et al. Culture-proven neonatal sepsis in Japanese neonatal care units in 2006–2008. Neonatology 2012; 102: 75–80.
13 Leal YA, Álvarez-Nemegyei J, Velázquez JR, et al. Risk factors and prognosis for neonatal sepsis in southeastern Mexico: analysis of a four-year historic cohort follow-up. BMC Pregnancy Childbirth 2012; 12: 48.
14 Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110:285–91.
15 Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: 2357–65.
16 Dong Y, Speer CP. The role of Staphylococcus epidermidis in neonatal sepsis: guarding angel or pathogenic devil? Int J Med Microbiol 2014; 304: 513–20.
17 Rasigade JP, Raulin O, Picaud JC, et al. Methicillin-resistant Staphylococcus capitis with reduced vancomycin susceptibility causes late-onset sepsis in intensive care neonates. PLoS ONE 2012; 7: e31548.
18 Lepainteur M, Royer G, Bourrel AS, et al. Prevalence of resistance to antiseptics and mupirocin among invasive coagulase-negative staphylococci from very preterm neonates in NICU: the creeping threat? J Hosp Infect 2013; 83: 333–6.
19 Tsai MH, Chu SM, Hsu JF, et al. Risk factors and outcomes for multidrug- resistant Gram-negative bacteremia in the NICU. Pediatrics 2014; 133: e322–9.
20 Meem M, Modak JK, Mortuza R, et al. Biomarkers for diagnosis of neonatal infections: A systematic analysis of their potential as a point-of-care diagnostics. J Glob Health 2011; 1: 201–9.
21 Ng PC, Lam HS. Biomarkers in neonatology: the next generation of tests. Neonatology 2012; 102:145–51.
22 Kasper DC, Altiok I, Mechtler TP, et al. Molecular detection of late-onset neonatal sepsis in premature infants using small blood volumes: proof-of-concept. Neonatology 2013; 103: 268–73.
23 Edmond K, Zaidi A. New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Med 2010; 7: e1000213.
24 Altun O, Almuhayawi M, Ullberg M, et al. Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol 2013; 51:4130–6.
25 Cernada M, Serna E, Bauerl C, et al. Genome-wide expression in profiles in very low birth weight infants with neonatal sepsis. Pediatrics 2014; 133 e1203–11.
26 Fairchild KD. Predictive monitoring for early detection of sepsis in neonatal ICU patients. Curr Opin Pediatr 2013; 25:172–9.
27 Moorman JR, Carlo WA, Kattwinkel J, et al. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J Pediatr 2011; 159: 900–6.
28 Manzoni P, Mostert M, Stronati M. Lactoferrin for prevention of neonatal infections. Curr Opin Infect Dis 2011; 24:177–82.
29 Bion J, Richardson A, Hibbert P, et al. ‘Matching Michigan’: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. BMJ Qual Saf 2013; 22:110–23.
30 Kaplan HC, Lannon C, Walsh MC, et al. Ohio statewide quality-improvement collaborative to reduce late-onset sepsis in preterm infants. Pediatrics 2011; 127:427–35.
31 Bersani I, Speer CP. Nosocomial sepsis in neonatal intensive care: inevitable or preventable? Z Geburtshilfe Neonatol 2012; 216:186–90.
32 Gastmeier P, Sohr D, Schwab F, et al. Ten years of KISS: the most important requirements for success. J Hosp Infect 2008; 70 (Suppl 1):11–16.
33 Tourneur E, Chassin C. Neonatal immune adaptation of the gut and its role during infections. Clin Dev Immunol 2013; 2013:270301.
34 Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635–8.
35 Fanaro S, Chierici R, Guerrini P, et al. Intestinal microflora in early infancy: composition and development. Acta Paediatr 2003; 91:48–55.
36 Madan JC, Salari RC, Saxena D, et al. Gut microbial colonisation in premature neonates predicts neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2012; 97: F456–62.
37 Garland SM, Tobin JM, Pirotta M, et al. The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants. BMC Infect Dis 2011; 11:210.
38 Sherman MP. New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention. Clin Perinatol 2010; 37:565–79.
39 Gewolb IH, Schwalbe RS, Taciak VL, et al. Stool microflora in extremely low birth weight infants. Arch Dis Child 1999; 80:F167–73.
40 Stewart CJ, Marrs EC, Magorrian S, et al. The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection. Acta Paediatr 2012; 101:1121–7.
41 Nair V, Soraisham AS. Probiotics and prebiotics: role in prevention of nosocomial sepsis in preterm infants. Int J Pediatr 2013; 2013:874726.
42 Jacobs SE, Tobin JM, Opie GF, et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 2013; 132:1055–62.
43 Hay WW Jr. Strategies for feeding the preterm infant. Neonatology 2008; 94:245–54.
44 Morgan J, Bombell S, McGuire W. Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants. Cochrane Database Syst Rev 2013; 3: CD000504.
45 Sweeney B, Puri P, Reen DJ. Induction and modulation of apoptosis in neonatal monocytes by polyunsaturated fatty acids. J Pediatr Surg 2007; 42:620–8.
46 Flidel-Rimon O, Friedman S, Lev E, et al. Early enteral feeding and nosocomial sepsis in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2004; 89: F289–92.
47 Rønnestad A, Abrahamsen TG, Medbø S, et al. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics 2005; 115:e269–76.
48 Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 2007; 61:2–8.
49 Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009; 302:1421–8.
50 Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011 ;( 10):CD007137.
51 Kuhn P, Messer J, Paupe A, et al. A multicenter, randomized placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia. J Pediatr 2009; 155:324–30.
52 Carr R, Brocklehurst P, Doré CJ, et al. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): single-blind, multicentre randomized controlled trial. Lancet 2009; 373:226–33.
53 Fanaroff AA, Korones SB, Wright LL, et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1994;330:1107–13.
54 Brocklehurst P, Farrell B, King A, et al; INIS Collaborative Group. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011; 365:1201–11.
55 DeJonge M, Burchfield D, Bloom B, et al. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 2007; 151:260–5.
56 Levy O, Wynn JL. A prime time for trained immunity: innate immune memory in newborns and infants. Neonatology 2014; 105:136–41.
57 Quach C, Milstone AM, Perpête C, et al. Chlorhexidine Bathing in a Tertiary Care Neonatal Intensive Care Unit: Impact on Central Line–Associated Bloodstream Infections. Infect Control Hosp Epidemiol 2014; 35:158–63.
58 Sankar MJ, Paul VK. Efficacy and safety of whole body skin cleansing with chlorhexidine in neonates—a systemic review. Pediatr Infect Dis J 2013;32: e227–34.
59 Ponnusamy V, Venkatesh V, Clarke P. Skin antisepsis in the neonate: what should we use? Curr Opin Infect Dis 2014; 27:244–50.
60 Ness MJ, Davis DM, Carey WA. Neonatal skin care: a concise review. Int J Dermatol 2013; 52:14–22.
61 Tollin M, Jagerbrink T, Haraldsson A, et al. Proteome analysis of vernix caseosa. Pediatr Res 2006; 20:430–4.
62 Cogen AL, Nizet V, Gallo RL. Skin microbiota: a source of disease or defence? Br J Dermatol 2008; 158:442–55.
63 Russell AB, Sharland M, Heath PT. Improving antibiotic prescribing in neonatal units: time to act. Arch Dis Child Fetal Neonatal Ed 2012; 97:F141–6.
64 Muller-Pebody B, Johnson AP, Heath PT, et al. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011; 96:F4–8.
65 Fernando AM, Heath PT, Menson EN. Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland. J Antimicrob Chemother 2008; 61:743–5.
66 Anthony M, Bedford-Russell A, Cooper T, et al. Managing and preventing outbreaks of Gram-negative infections in UK neonatal units. Arch Dis Child Fetal Neonatal Ed 2013; 98:F549–53.
67 Kuppala VS, Meinzen-Derr J, Morrow AL, et al. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011; 159:720–5.
68 Lesprit P, Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis 2008;21:344–9.
Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí